 Home
Research
Programs
Selected
Publications
Stories
Behind Discovery
Protein
Models & Hypothesis
Affiliations
& Address
Snap Shots
Page 1
Page 2
Page 3
|
|
Protein Structure and Function; Gene
Expression; Molecular Endocrinology and Transgenic Fish
Our laboratory is one of the leading groups in the study of fish antifreeze proteins, the
molecular endocrinology of fish pituitary hormones and the biotechnological applications
of transgenic fish.
1. Antifreeze Proteins.
The antifreeze proteins (AFPs) are a group of proteins that have the unique property of
inhibiting ice crystal formation and ice recrystallization (Fig. 1). These proteins are essential for
the survival of many organisms living in icy environment. These proteins are therefore
important and interesting models to study protein-ice interaction, biochemical adaptation
and gene expression by environmental factors.
Protein structure and function.
We are the first group to report the isolation and the primary structure of the different
fish AFPs including the winter flounder, shorthorn sculpin, ocean pout and sea raven and
their subsequent cDNA cloning (for detail references, please see Yang and Hew, European J.
Biochemistry, vol 203, 33-42,1992). These studies established their structural diversity
and allowed us to classify them into different types of AFPs. We are the first to report
the three dimensional structure of a type I AFP (Fig. 2) from winter flounder using X ray
crystallography (Yang et al., Nature 333, 232-237, 1988) and the first to carry out
extensive structure-function study using peptide synthesis and site directed mutagenesis.
The x ray structure of the type III ocean pout AFP (Fig. 4) has also been resolved and a
model of a type II herring AFP (Fig. 3)
was constructed based on its homology with the C type lectins. The availability of these
models will allow us to carry extensive mutagenesis study to examine the structure and
function of these proteins. More recently, our laboratories also discovered a novel,
intracellular AFP from the winter flounder and shorthorn sculpin. These new AFPs are
different from other secretory AFPs reported earlier in that they lacked signal peptides
and are intracellularly localized. The occurrence of both the intracellular and
extracellular AFPs has raised many interesting questions on the relative role of those
proteins in freeze protection, their differential regulation and evolution. These
questions are now being actively pursued in the laboratory. Because of our work, many
laboratories are now actively pursuing the application of these proteins in the food and
dairy industry, cryopreservation of cells and tissues, cold storage of human platelet
cells and the development of cold/freeze resistant transgenic plans and animals in
addition to basic research.
Control of gene
expression. Using the winter flounder as a model, we are
the first to
examine the role of the environmental and endocrine factors in controlling
AFP gene
expression on a seasonal level. We have demonstrated that growth hormone
(GH) inhibits AFP
gene expression. On a molecular level, we further show that the intron of
the AFP gene
contains a liver-specific enhancer. The role of an enhancer element and some
of the cis
acting elements mediating AFP gene transcription were mapped (Chan et al.,
European J.
Biochem, vol 247, 44-51,1997). Two transcription factors, C/EBP and a presumptive Antifreeze Enhancer Binding Protein
(AEP) bind to the enhancer sequence and activate AFP gene expression. A working model (Fig. 5) illustrating the control
mechanisms for regulating flounder AFP gene expression is being tested.

2. Molecular endocrinology of fish
pituitary hormones. The pituitary
gland contains several polypeptide hormones important in somatic growth, reproduction,
homeostasis, lactation, adaptation and other functions. We are one of the first groups to
take a molecular approach to the studies of comparative endocrinology. We were the first
to clone the fish gonadotropin (GTH), prolactin and several fish transcription factors
important to pituitary functions which include pit-1, Isl-1and steroidogenic factor-1
(SF-1). More recently we are first to demonstrate that the synergistic interaction of
steroidogenic factor-1 and estrogen receptor are sufficient to confer the tissue and cell
type specific expression of the GTHII gene (Le Drean et al., Molecular Endocrinology, vol 10,
217-229,1996). A model (Fig. 6)
showing the interaction of these factors in activating GTHII gene promoter is included. We are now focusing on the structural features
important in protein-protein interaction and the functional domains important for
transcriptional regulation.
3. Transgenic fish.
We are the first group to explore the use of transgenic
fish in basic research and biotech applications. We invented the microinjection
technique
via the micropyle and the development of "All Fish" gene constructs
for the use
in aquaculture. We have successfully produced transgenic salmon harboring
the antifreeze
protein gene (for freeze resistance), growth hormone (for growth enhancement)
and lysozyme
(for disease resistance). Our growth hormone-transgenic salmon was the first
to exhibit 5
to 10 fold enhanced growth rate (Du et al., BioTechnology, vol 10(2), 176-181,
1992, Super
salmon (Fig. 7) and was also the
first transgenic fish issued by the U.S patent office (1996). Because of our work, a
biotech. company (A/F Protein Inc.) is actively marketing the technology and the
transgenic salmon worldwide. Presently, we are focusing methodology improvement for the
gene transfer methods and the development of other commercially important fish species.

      

Copyright @ 2000 PC Links.
Sept. 2000
|